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The Effects of Omega‐3‐Fatty Acids on Saccharomyces
Cerevisiae Inositol Pathway Mutants
Colon, Daniel and Murray-Nseula, Marlene
Department of Biology, Andrews University, Berrien Springs, Michigan 49104
ABSTRACT
Bipolar disease is a severe and chronic debilitating mental disorder affecting 1-3% of
the population. Omega-3-fatty acids have been shown to relieve symptoms of bipolar disorder
and are not associated with the negative side effects of lithium and valproate, two of the
commonly used drugs for treating this condition. The mechanism of action of omega-3-fatty
acids remains unknown. Therefore the purpose of this study was to determine if, like lithium and
valproate, omega-3-fatty acids affect inositol metabolism. This was accomplished by
investigating the effect of the omega-3-fatty acid docosahexanoic acid (DHA) on the growth of
inositol pathway mutants. To measure the effects of DHA we grew an inositol auxotrophic
mutant (SH1) and an inositol overproducing mutant (SH7) in the presence and absence of DHA
and compared the growth. The results were similar to previous studies done with valproate,
showing that in the absence of DHA, growth of the inositol overproducer is better than the
growth of the inositol auxotroph due to the abundance of inositol in the overproducing mutant.
The results also show that DHA inhibits growth of all strains including the inositol
overproducing strain. Therefore, it may be concluded DHA has an effect on the inositol pathway
since the decrease in growth of the overproducing strain may be due to a decrease in the inositol
levels of the overproducing strain by DHA.
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Introduction
Bipolar disorder, also known as manic-depressive illness is a mental condition that causes
very severe changes in a person’s mood, which can go from a very excited state to a depressive
state in a short period of time. Statistics show that around 1.5% of the United States population
currently suffer from this illness. Although there are some treatments, there is not a known cure
for bipolar disorder. One of the most common treatments of bipolar disease is lithium, which was
approved in the 1970s by the FDA as a treatment for this illness. Also in 1995, the FDA
approved valproic acid as another treatment for this condition.
Even though that these drugs are quite common and have helped some of the patients
treated, they are far from being perfect because they are not always effective and in many cases
cause some negative side effects. In the case of lithium, some patients treated with it have
suffered problems with their thyroid gland. For example, hypothyroidism, which can result in
weight gain, has been seen in some patients that have been exposed to lithium during their
treatment (Henry 2002). Also, another effect that has been associated with lithium treatment is
tremors (Gelenberg et al., 1995). Other neurological effects that are associated with the lithium
treatment include seizures, extrapyramidal effects, changes in electroencephalogram (EEG),
dizziness, speech problems and gastrointestinal effects like nausea and diarrhea (Ghadirian et al.,
1980).
Valproic acid has also been associated with several different side effects, although not as
severe as the ones associated with the use of lithium. Some of the side effects of the use of
valproic acid include: weakness, facial edema, vomiting, abdominal pain, nausea, vomiting,
nosebleed, blood clotting problems and lethargy (Kulick et al., 1993).
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Since the current treatments used to treat bipolar disorder are associated with negative
side effects there is a need for a better treatment for bipolar disorder. In order to start developing
better treatments, the molecular mechanism of the action of lithium and valproic acid has been
the subject of different research projects in the past few years. Studies have shown some
relationship between lithium and the inositol biosynthetic pathway. Lithium inhibits myo-1inositol monophosphatase, an enzyme whose function is involved in the recycling of inositol
(Murray and Greenberg, 1999; Parthasarathy 1997). Also valproic acid has been shown to affect
the inositol biosynthetic pathway by inhibiting an enzyme called myo-inositol phosphate
synthase which catalyzes the conversion of glucose-1-phosphate to myo-inositol-1-phosphate
(Shaltiel et.al 2004). Both drugs have been shown to decrease intracellular inositol levels (Vaden
et. al., 2001).
Research has shown that omega-3-fatty acids relieve some of the symptoms of the
patients with bipolar disease (Stoll et al. 1999). In addition, previous studies show that omega-3fatty acids inhibit phospholipase C (PLC), protein kinase C (PKC) and Inositol-3-phosphate
(IP3), all components of the inositol biosynthetic pathway (Mirnikjoo et al., 2001).
In preliminary work done in Dr. Murray-Nseula’s lab, it was shown that the omega-3fatty acid docosahexanoic acid (DHA) affects the growth of the yeast Saccharomyces cerevisiae
and that this inhibition is reversed in the presence of inositol. To further investigate the effect of
omega-3-fatty acids on the inositol biosynthetic pathway, in this study, I will use Saccharomyces
cerevisiae strains that have mutations in the inositol biosynthetic pathway that cause them to
either overproduce inositol (opi1) or to not be able to produce inositol (ino1). These strains were
grown in the presence or absence of DHA to determine if the inositol overproducing phenotype
is more resistant to growth inhibition by DHA and if the inositol auxotrophic phenotype is more
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sensitive to DHA. The purpose of this project is to test the effect of omega-3-fatty acids on the
inositol biosynthetic pathway. My null hypothesis is that the addition of DHA does not affect the
inositol levels on the yeast cells, hence the addition of DHA does not affect the growth of the
yeast cells.

Materials and Methods
Thawing yeast strains
For this project three different strains of the yeast Saccharomyces cerevisiae were used: an
inositol auxotroph- that does not produce inositol (SH1), an overproducer (SH7) and a wildtype
(SMY7). These strains were kept immortalized in microcentrifuge tubes in a freezer set to 80oC. A sample of each of the strains was taken using a sterile toothpick and was plated on YPD
plates and they were incubated for 72 hours at a temperature of approximately 30oC.
Growth Media
Two different types of media were made for the different strains’ needs (the media was made
using a recipe provided by instructor). One of the media lacked inositol (I-) and was used to grow
the overproducer and the wildtype strains. The other type of media contained inositol in a 10 µm
concentration. This was done because the inositol auxotrophic strain needed some inositol to be
able to grow.

Growth Conditions
After the 3 different thawed strains were grown for the 72 hours, a small sample from each of the
plates was put into a flask containing 100 ml of the media for each straing, using a sterile
toothpick. . The cultures were then grown in a shaking water bath overnight (18 hours) at
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150rpm and 30 oC. Once the 18 hours were done an optical density reading of each of the
cultures was done. In order to do this, 100 µl of each of the cultures were diluted with 900 µl of
media.
Samples of the overnight cultures were placed in the experimental media containing or lacking
DHA. The amount of each culture used was dependent on the optical density reading.; the
formula M1V1=M2V2 was used (M1= optical density reading, M2= desired concentration of .1, V1
was the amount of culture that was needed to be put into the flask that was going to have DHA
and V2= 100mL of media). The experimental cultures were taken to grow for 24 hours in a
shaking water bath at 150 rpm and 30oC.

Colony plating and counting
After the 24 hours,, an optical density reading of each of the culture was taken, 100 µl a 10-5
serial dilution was plated on YPD plates and incubated for 72 hours, at which time colonies were
counted.
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Results
Table 1.1 Total number of colonies.

1

2

3

4

Strain

DHA+

DHA-

DHA+

DHA-

DHA+

DHA-

DHA+

DHA-

SH1

122

146

173

608

161

231

123

365

SH7

147

399

255

950

191

408

207

513

0

262

297

72

203

139

214

Wildtype 0

The table represents the results of four separate trials. It shows the number of colonies counted
on each of the runs for each of the strain in the presence and absence of DHA.
The wildtype strain used in this experiment did not grow as expected during the first run, so first
run of the experiment was completed with only the SH1 and SH7 strains.

Table 2.1 Average number of colonies
Strain

DHA+

DHA -

SH1

145

338

SH7

191

568

Wildtype

158

238

Table 2.1 contains the average number of colonies grown of each of the strains in the presence
and absence of DHA.
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Figure 1.1 Graphical representation of average number of colonies

DHA+
DHA‐

Discussion
What we expected to find as we grew the different strains in the presence and absence of
DHA, was that the number of colonies should have decreased when the DHA was present in all
of the strains. From the data it can be seen that when the DHA was added the growth of cells
decreased significantly in the case of the SH1 strain (χ² = 6.79, df = 2, p < 0.01) and the SH7
strain (χ² = 7.84, df = 2, p < 0.01), which supports our expectations for these 2 strains. In the case
of the wildtype our data is not as significant as we would have expected. The fact that our data
for the wildtype strain was not significant was probably because our sample size was not large
enough since in the first run of the experiment we did not get any growth of these type of cells,
the acquisition of more data could have made our results more concrete and statistically
significant.
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Also, it was observed that the overproducer strain grew better than both the wildtype and
the inositol auxotroph in the presence of DHA. This was as expected since in the overproducer
strain there were larger concentrations of inositol, which promotes the growing of the colonies.
However, an important detail is that when DHA was added, the growth of all the colonies
decreased to about the same level, which suggests that the decrease in the growth is due to the
decrease in inositol levels.
Another interesting observation was that in the absence of DHA the SH1 strain grew
better than the wildtype. We expected the contrary since the wildtype was able to produce its
own inositol and the SH1 strain was not. The results obtained might have been due to the fact
that we added 10 µm inositol to the media in which the SH1 grew thus creating an environment
containing more inositol than that produced by the wildtype.
Although the results support our expectation, there are other studies that could be done in
order to support the data gotten in this research project. For example, the actual inositol
concentration levels could be measured by spectrophotometry in cells grown in the presence or
absence of DHA.
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